An experimental treatment improves the cognitive ability and gut microbiota of mice with fragile X syndrome
Ongoing treatment with a drug that inhibits the endocannabinoid system peripherally improves memory deficits, reduces synaptic alterations, mitigates gut microbiota dysbiosis and restores intestinal…